1.85
-0.02(-1.07%)
Currency In USD
| Previous Close | 1.87 |
| Open | 1.9 |
| Day High | 1.93 |
| Day Low | 1.81 |
| 52-Week High | 5.6 |
| 52-Week Low | 0.87 |
| Volume | 91,960 |
| Average Volume | 266,458 |
| Market Cap | 73.18M |
| PE | -1.37 |
| EPS | -1.35 |
| Moving Average 50 Days | 1.2 |
| Moving Average 200 Days | 2.29 |
| Change | -0.02 |
If you invested $1000 in TELA Bio, Inc. (TELA) since IPO date, it would be worth $138.58 as of June 13, 2025 at a share price of $1.85. Whereas If you bought $1000 worth of TELA Bio, Inc. (TELA) shares 5 years ago, it would be worth $101.15 as of June 13, 2025 at a share price of $1.85.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Jun 06, 2025 8:05 PM GMT
MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by priori
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
GlobeNewswire Inc.
Jun 03, 2025 8:05 PM GMT
Based on market research, inguinal hernia repair is the most common type of hernia repairMALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative so
TELA Bio Appoints Jeffrey Blizard as President
GlobeNewswire Inc.
Jun 02, 2025 12:30 PM GMT
Company Further Strengthens Executive Leadership Team to Drive Next Phase of GrowthMALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissu